Mayo Designed Soft Tissue Ultrasound-Detectable Marker

Status Completed

Clinical Trial Summary

Researchers are trying to determine if the Mayo marker is easily seen with ultrasound making it easier, faster, and more accurate for preoperative localization of the biopsied positive lymph node.

Clinical Trial Description

Nonrandomized clinical trial to evaluate the Mayo-designed marker for ultrasound conspicuity at the time of preoperative ultrasound-guided localization. Study participants are breast cancer patients with pathology-proven metastatic axillary lymph nodes. Per standard of care, a biopsy marker will have already been associated with the positive lymph node. 10 such patients scheduled for surgery at Mayo Clinic Rochester, MN with Dr. James Jakub will be enrolled. Preoperative radioactive seed localization will proceed as usual, but the marker will be additionally loaded with the seed into the needle using standard protocol. Before surgery, ultrasound will be performed to evaluate the marker. ;

Study Design

Related Conditions & MeSH terms

Breast Neoplasm Female
Breast Neoplasms
Ultrasound Therapy; Complications

Clinical Trial Details

NCT number	NCT04674852
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	N/A
Start date	November 2, 2020
Completion date	April 7, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03980626` - Study on Physical Activity's Relationship With Cancer and Cognition	N/A
Completed	`NCT04329819` - Satisfaction and QUality of Life After Breast REconstruction
Recruiting	`NCT03323346` - Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer	Phase 2
Active, not recruiting	`NCT03900884` - Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer	Phase 1
Completed	`NCT05042999` - The Use of Virtual Reality During Breast Ultrasound-Guided Biopsy Procedures	N/A
Not yet recruiting	`NCT03662633` - Diagnosis Value of SEMA4C in Breast Cancer
Recruiting	`NCT05075512` - The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer	Phase 2
Recruiting	`NCT04456855` - Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients
Not yet recruiting	`NCT03629509` - BEFORE Decision Aid Implementation Study	N/A
Completed	`NCT04811378` - HaemoCerTM Application in Breast Cancer Surgery	N/A
Completed	`NCT03198442` - Breast PET Feasibility	N/A
Not yet recruiting	`NCT05577442` - Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer	Phase 2
Enrolling by invitation	`NCT04047823` - Temperature and Injury in Radiotherapy Radiation Skin Injury
Recruiting	`NCT05452213` - Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients	Phase 4
Recruiting	`NCT05027321` - Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies	N/A
Active, not recruiting	`NCT04812652` - Digitally Distributed Yoga for Women Treated for Breast Cancer	N/A
Active, not recruiting	`NCT03425838` - Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer	Phase 3
Completed	`NCT05473026` - Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors	N/A
Completed	`NCT04509063` - Investigating Public Enthusiasm for Mammography Screening in Denmark	N/A
Recruiting	`NCT05711030` - Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery	N/A